Business Description
NexImmune Inc
NAICS : 541713
SIC : 2834
ISIN : US65344D2080
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 67.33 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.02 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 5.1 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | 4.5 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 52.35 | |||||
14-Day RSI | 49.76 | |||||
12-1 Month Momentum % | -48.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 0.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.5 | |||||
Shareholder Yield % | 14.93 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -191.06 | |||||
ROA % | -134.37 | |||||
ROIC % | -628.98 | |||||
ROC (Joel Greenblatt) % | -775.66 | |||||
ROCE % | -188.4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 0.96 | |||||
EV-to-FCF | 0.01 | |||||
Price-to-Net-Current-Asset-Value | 10.58 | |||||
Earnings Yield (Greenblatt) % | 48800 | |||||
FCF Yield % | -698.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NexImmune Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -28.715 | ||
Beta | 2.03 | ||
Volatility % | 28.44 | ||
14-Day RSI | 49.76 | ||
14-Day ATR (€) | 0.000019 | ||
20-Day SMA (€) | 4.55 | ||
12-1 Month Momentum % | -48.88 | ||
52-Week Range (€) | 4.025 - 11.05 | ||
Shares Outstanding (Mil) | 1.37 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NexImmune Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NexImmune Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
NexImmune Inc Frequently Asked Questions
What is NexImmune Inc(STU:7370)'s stock price today?
When is next earnings date of NexImmune Inc(STU:7370)?
Does NexImmune Inc(STU:7370) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |